Signaling to NF-κB by Toll-like receptors | 2007/11/01 | English | 1,662 |
MicroRNAs in cancer: biomarkers, functions and therapy | 2014/08/01 | English | 1,397 |
Nrf2–Keap1 defines a physiologically important stress response mechanism | 2004/11/01 | English | 1,329 |
DNA damage-induced cell death by apoptosis | 2006/09/01 | English | 1,068 |
Inflammatory networks during cellular senescence: causes and consequences | 2010/05/01 | English | 863 |
RANKL–RANK signaling in osteoclastogenesis and bone disease | 2006/01/01 | English | 818 |
CD39 and CD73 in immunity and inflammation | 2013/06/01 | English | 813 |
MITF: master regulator of melanocyte development and melanoma oncogene | 2006/09/01 | English | 795 |
Sialic acids in human health and disease | 2008/08/01 | English | 698 |
Microbiota and neurodevelopmental windows: implications for brain disorders | 2014/09/01 | English | 690 |
Carbapenem resistance in Enterobacteriaceae: here is the storm! | 2012/05/01 | English | 686 |
Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease | 2008/02/01 | English | 645 |
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease | 2009/03/01 | English | 624 |
The infant microbiome development: mom matters | 2015/02/01 | English | 578 |
Protein S-nitrosylation in health and disease: a current perspective | 2009/09/01 | English | 540 |
The tripartite synapse: roles for gliotransmission in health and disease | 2007/02/01 | English | 533 |
Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway | 2015/01/01 | English | 532 |
MicroRNA expression and function in cancer | 2006/12/01 | English | 530 |
Antibiotic-Induced Changes in the Intestinal Microbiota and Disease | 2016/06/01 | English | 524 |
MUC1: a multifaceted oncoprotein with a key role in cancer progression | 2014/06/01 | English | 524 |
Circulating tumour cells in cancer patients: challenges and perspectives | 2010/09/01 | English | 507 |
The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer | 2008/03/01 | English | 504 |
Cell-penetrating peptides: breaking through to the other side | 2012/07/01 | English | 500 |
Natural regulatory T cells: mechanisms of suppression | 2007/03/01 | English | 491 |
Disease Modeling in Stem Cell-Derived 3D Organoid Systems | 2017/05/01 | English | 485 |
Cancer nanomedicine: from targeted delivery to combination therapy | 2015/04/01 | English | 484 |
Endoplasmic reticulum stress, obesity and diabetes | 2012/01/01 | English | 484 |
The role of pyocyanin in Pseudomonas aeruginosa infection | 2004/12/01 | English | 481 |
Chemokines and chemokine receptors: new insights into cancer-related inflammation | 2010/03/01 | English | 481 |
Why have clinical trials in sepsis failed? | 2014/04/01 | English | 468 |